We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Bioengineers Present Glucose Monitor Tattoo Prototype

By LabMedica International staff writers
Posted on 25 Jan 2015
A team of bioengineers has presented a prototype "proof-of-concept" version of a temporary tattoo that is able to extract and measure the level of glucose in the fluid between human skin cells.

The flexible, easy to wear device consists of a pattern of electrodes printed on temporary tattoo paper that is attached to the skin. More...
When a mild electrical current is applied to the skin for about 10 minutes, sodium ions and glucose molecules in the interstitial fluid migrate toward the tattoo's electrodes. A sensor built into the tattoo measures the strength of the electrical charge produced by the glucose to determine the patient's overall glucose level.

In a preliminary study, tattoos were applied to seven men and women between the ages of 20 and 40 with no history of diabetes. The volunteers were fed a carbohydrate-rich meal, and glucose levels were monitored by the tattoo and compared to those obtained by the traditional finger-stick method. Results showed that the tattoos detected the glucose spike following the meal with the same level of accuracy as the finger-stick.

"The concentration of glucose extracted by the noninvasive tattoo device is almost hundred times lower than the corresponding level in the human blood," said first author Amay Bandodkar, a graduate researcher at the University of California, San Diego (USA). "Thus we had to develop a highly sensitive glucose sensor that could detect such low levels of glucose with high selectivity. Eventually the instrument will also have Bluetooth readout capabilities to send this information directly to the patient's doctor in real-time or store data in the cloud. Presently the tattoo sensor can easily survive for a day. These are extremely inexpensive—a few cents—and hence can be replaced without much financial burden on the patient."

The paper describing the potential for glucose monitoring with a noninvasive flexible tattoo was published in the December 12, 2014, online edition of the journal Analytical Chemistry.

Related Links:

University of California, San Diego



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Chagas Disease Test
LIAISON Chagas
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.